ATE107661T1 - Hrsv-vakzine. - Google Patents

Hrsv-vakzine.

Info

Publication number
ATE107661T1
ATE107661T1 AT91913753T AT91913753T ATE107661T1 AT E107661 T1 ATE107661 T1 AT E107661T1 AT 91913753 T AT91913753 T AT 91913753T AT 91913753 T AT91913753 T AT 91913753T AT E107661 T1 ATE107661 T1 AT E107661T1
Authority
AT
Austria
Prior art keywords
hrsv
disclosed
hrsv vaccine
vaccine
peptides
Prior art date
Application number
AT91913753T
Other languages
English (en)
Inventor
Judith A Nicholas
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE107661T1 publication Critical patent/ATE107661T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT91913753T 1990-08-31 1991-07-30 Hrsv-vakzine. ATE107661T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57589290A 1990-08-31 1990-08-31

Publications (1)

Publication Number Publication Date
ATE107661T1 true ATE107661T1 (de) 1994-07-15

Family

ID=24302113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91913753T ATE107661T1 (de) 1990-08-31 1991-07-30 Hrsv-vakzine.

Country Status (11)

Country Link
EP (1) EP0545951B1 (de)
JP (1) JP3108095B2 (de)
KR (1) KR100227157B1 (de)
AT (1) ATE107661T1 (de)
AU (1) AU644470B2 (de)
CA (1) CA2087003C (de)
DE (1) DE69102649T2 (de)
DK (1) DK0545951T3 (de)
ES (1) ES2055610T3 (de)
HK (1) HK65197A (de)
WO (1) WO1992004375A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2718452B1 (fr) 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
US5789229A (en) * 1994-09-30 1998-08-04 Uab Research Foundation Stranded RNA virus particles
US5716821A (en) * 1994-09-30 1998-02-10 Uab Research Foundation Prevention and treatment of respiratory tract disease
FR2726472B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
EP1514120A2 (de) * 2002-06-20 2005-03-16 De Staat der Nederlanden, vert. door de minister van VWS Immundominante mhc klasse ii spezifische peptide, abgeleit vom fusionsprotein (f) und dem rezeptorbindenden protein (g) desrsv

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines

Also Published As

Publication number Publication date
DE69102649D1 (de) 1994-07-28
CA2087003A1 (en) 1992-03-01
AU8298291A (en) 1992-03-30
AU644470B2 (en) 1993-12-09
WO1992004375A1 (en) 1992-03-19
JP3108095B2 (ja) 2000-11-13
EP0545951A1 (de) 1993-06-16
ES2055610T3 (es) 1994-08-16
DE69102649T2 (de) 1994-11-03
JPH06500536A (ja) 1994-01-20
KR100227157B1 (ko) 1999-10-15
EP0545951B1 (de) 1994-06-22
HK65197A (en) 1997-05-23
CA2087003C (en) 2001-05-08
DK0545951T3 (da) 1994-10-17

Similar Documents

Publication Publication Date Title
FI963281A0 (fi) Ureaasipohjainen rokote ja helicobakteeri-infektion hoito
FI971732A7 (fi) Rokote ja antitoksiini C. difficilen aiheuttaman taudin hoitamiseksi j a estämiseksi
FI951164L (fi) Respiratory syncytial -viruksen vastaiset neutraloivat ihmisen monoklonaaliset vasta-aineet
FI943171L (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
HUP9903169A3 (en) Low pathogenicity prrs live virus vaccines and methods of preparation thereof
ATE163682T1 (de) Respiratorisches syncytiales virus, impstoffe
CY2007030I1 (el) Εμβολιο εναντια στον ανθρωπινο ϊο θηλωματος (τυπος 18)
MX9202781A (es) Vacuna y metodo de tratamiento para virus de inmunodeficiencia humana.
FI955150A7 (fi) OspC-antigeenirokotteiden immunogeenisia formulaatioita lyymisairauden ehkäisyyn ja hoitoon ja rekombinanttimenetelmiä antigeenien valmistam iseksi
NO943653D0 (no) Rekombinante, humane HIV-nöytraliserende monoklonale antistoffer for forebyggelse og behandling av HIV-infeksjon
ZA927014B (en) Chicken anaemia agent vaccine.
DK0545951T3 (da) HRSV-vaccine
FI915702A7 (fi) Peptidejä ja niistä johdettuja vasta-aineita HTLV-1 infektion vastaise n rokotuksen määrittämiseksi
ES2159287T3 (es) Peptidos hemorreguladores.
LV10191A (lv) Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai
NO912942D0 (no) Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.
FI953371L (fi) TBE-virusinfektiota vastaan tähtäävään immunisointiin tarkoitetut parannetut rokotteet sekä menetelmä niiden valmistamiseksi
ITMI913493A1 (it) Dispositivo per la disinfezione o la immunizzazione di zone del corpo umano esposte al contagio, da germi, batteri e virus
FI971403A0 (fi) Menetelmä voimistettujen antigeenisten enteeristen bakteerien ja niitä sisältävien rokotteiden tuottamiseksi
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
FI930519A7 (fi) Peptiidejä HIV-viruksen aiheuttaman infektion torjumiseksi sekä menete lmä niiden käyttämiseksi
BR1100531A (pt) Composições de vacina de vìrus sincicial respiratório atenuado
BR1100802A (pt) Formulação de vacina contra vìrus respiratório sincicial
ITRM910384A0 (it) Procedimento di preparazione di vaccini anti-influenzali e vaccini conesso ottenuti.
UA25724A (uk) Вакциhа респіh для профілактики гострих респіраторhих хвороб молодhяка твариh

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time